165 related articles for article (PubMed ID: 19348910)
1. The role of metallothionein in oncogenesis and cancer prognosis.
Pedersen MØ; Larsen A; Stoltenberg M; Penkowa M
Prog Histochem Cytochem; 2009; 44(1):29-64. PubMed ID: 19348910
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
[TBL] [Abstract][Full Text] [Related]
3. Expression of metallothioneins in tumor cells.
Dziegiel P
Pol J Pathol; 2004; 55(1):3-12. PubMed ID: 15195701
[TBL] [Abstract][Full Text] [Related]
4. Metallothioneins in human tumors and potential roles in carcinogenesis.
Cherian MG; Jayasurya A; Bay BH
Mutat Res; 2003 Dec; 533(1-2):201-9. PubMed ID: 14643421
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression.
Cardoso SV; Caliari MV; de Aguiar MC; Cassali GD
Oncol Rep; 2004 Dec; 12(6):1317-21. PubMed ID: 15547757
[TBL] [Abstract][Full Text] [Related]
6. Metallothioneins are multipurpose neuroprotectants during brain pathology.
Penkowa M
FEBS J; 2006 May; 273(9):1857-70. PubMed ID: 16640552
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-I+II in neuroprotection.
Pedersen MØ; Jensen R; Pedersen DS; Skjolding AD; Hempel C; Maretty L; Penkowa M
Biofactors; 2009; 35(4):315-25. PubMed ID: 19655389
[TBL] [Abstract][Full Text] [Related]
8. [Metallothionein and cancer].
Li X; Ru B
Wei Sheng Yan Jiu; 1999 May; 28(3):185-7. PubMed ID: 12712730
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
11. The role of metallothionein in oncogenesis and cancer treatment.
Bizoń A; Jędryczko K; Milnerowicz H
Postepy Hig Med Dosw (Online); 2017 Feb; 71(0):98-109. PubMed ID: 28258670
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer.
Likui W; Qun L; Wanqing Z; Haifeng S; Fangqiu L; Xiaojun L
J Surg Oncol; 2009 Oct; 100(5):396-400. PubMed ID: 19582795
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: its prevention by metallothionein.
Liu Q; Wang G; Zhou G; Tan Y; Wang X; Wei W; Liu L; Xue W; Feng W; Cai L
Toxicol Lett; 2009 Dec; 191(2-3):314-20. PubMed ID: 19808082
[TBL] [Abstract][Full Text] [Related]
14. Biologic markers in endometrial cancer treatment.
Engelsen IB; Akslen LA; Salvesen HB
APMIS; 2009 Oct; 117(10):693-707. PubMed ID: 19775337
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
Chang X; Jin T; Chen L; Nordberg M; Lei L
Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein expression in human neoplasia.
Theocharis SE; Margeli AP; Klijanienko JT; Kouraklis GP
Histopathology; 2004 Aug; 45(2):103-18. PubMed ID: 15279628
[TBL] [Abstract][Full Text] [Related]
18. Expression of functional metallothionein isoforms in papillary thyroid cancer.
Liu ZM; Hasselt CA; Song FZ; Vlantis AC; Cherian MG; Koropatnick J; Chen GG
Mol Cell Endocrinol; 2009 Apr; 302(1):92-8. PubMed ID: 19356627
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
Martins I; Sylla K; Deshayes F; Lauriol J; Ghislin S; Dieu-Nosjean MC; Viguier M; Verola O; Charron D; Alcaide-Loridan C; Al-Daccak R
Melanoma Res; 2009 Aug; 19(4):226-37. PubMed ID: 19574933
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
